选择性环氧化酶抑制剂：新型1,2 - 二芳基环戊烯是强效且口服有效的COX - 2抑制剂。 - Suppr

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.

作者信息

Reitz D B, Li J J, Norton M B, Reinhard E J, Collins J T, Anderson G D, Gregory S A, Koboldt C M, Perkins W E, Seibert K

机构信息

Searle Research & Development, Chesterfield, Missouri 63198.

出版信息

J Med Chem. 1994 Nov 11;37(23):3878-81. doi: 10.1021/jm00049a005.

DOI:10.1021/jm00049a005

PMID:7966148

Abstract

摘要

相似文献

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.

J Med Chem. 1994 Nov 11;37(23):3878-81. doi: 10.1021/jm00049a005.

1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.

J Med Chem. 1995 Oct 27;38(22):4570-8. doi: 10.1021/jm00022a023.

2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.

J Med Chem. 1999 Apr 8;42(7):1274-81. doi: 10.1021/jm980642l.

Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.

J Med Chem. 1996 Apr 26;39(9):1846-56. doi: 10.1021/jm950878e.

Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.

J Med Chem. 2000 Aug 10;43(16):3168-85. doi: 10.1021/jm0000719.

1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.

J Med Chem. 1997 May 23;40(11):1634-47. doi: 10.1021/jm9700225.

Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors.

J Med Chem. 2000 Jan 27;43(2):214-23. doi: 10.1021/jm991106b.

Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.

J Med Chem. 1999 Apr 8;42(7):1161-9. doi: 10.1021/jm980570y.

In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.

J Med Chem. 2004 Feb 12;47(4):792-804. doi: 10.1021/jm020545z.

J Med Chem. 1999 Apr 8;42(7):1151-60. doi: 10.1021/jm9805081.

引用本文的文献

COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.

Br J Pharmacol. 2017 Aug;174(16):2696-2705. doi: 10.1111/bph.13893. Epub 2017 Jun 29.

Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

Free Radic Biol Med. 2015 Jun;83:101-14. doi: 10.1016/j.freeradbiomed.2015.01.029. Epub 2015 Feb 4.

Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).

Methods Mol Biol. 2015;1260:149-64. doi: 10.1007/978-1-4939-2239-0_9.

Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions.

Mol Pharm. 2012 Oct 1;9(10):2912-23. doi: 10.1021/mp300237z. Epub 2012 Aug 31.

A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem.

J Cheminform. 2009 Apr 28;1:4. doi: 10.1186/1758-2946-1-4.

Diverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.

J Comb Chem. 2010 Mar 8;12(2):278-85. doi: 10.1021/cc900172u.

Cyclooxygenase-2 and its regulation in inflammation.

Mediators Inflamm. 1996;5(5):305-23. doi: 10.1155/S0962935196000452.

Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands.

J Comput Aided Mol Des. 2006 Jun;20(6):343-60. doi: 10.1007/s10822-006-9051-5. Epub 2006 Sep 29.

Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10966-71. doi: 10.1073/pnas.95.18.10966.

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Drugs. 1997 Apr;53(4):563-82. doi: 10.2165/00003495-199753040-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.

作者信息

Reitz D B, Li J J, Norton M B, Reinhard E J, Collins J T, Anderson G D, Gregory S A, Koboldt C M, Perkins W E, Seibert K

机构信息

Searle Research & Development, Chesterfield, Missouri 63198.

出版信息

J Med Chem. 1994 Nov 11;37(23):3878-81. doi: 10.1021/jm00049a005.

DOI:10.1021/jm00049a005

PMID:7966148

Abstract

摘要

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献